- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.04. | Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M | 4 | Seeking Alpha | ||
| 15.04. | Novo Integrated Sciences, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 15.04. | Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results | 76 | Business Wire | BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary... ► Artikel lesen | |
| 10.04. | Novo Integrated Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.03. | Novo Integrated Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.03. | Novo Integrated Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.02. | Novo Integrated Sciences secures Nasdaq compliance waiver | 2 | Investing.com | ||
| 16.02. | Novo Integrated Sciences appoints new president | 3 | Investing.com | ||
| 15.02. | Novo Integrated Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 22.01. | Novo Integrated Sciences GAAP EPS of -$0.28, revenue of $3.89M | 4 | Seeking Alpha | ||
| 22.01. | Novo Integrated Sciences, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22.01. | Novo Integrated Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results | 150 | Business Wire | BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary... ► Artikel lesen | |
| 16.01. | Novo Integrated Sciences, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
| 14.12.23 | Novo Integrated Sciences GAAP EPS of -$1.30, revenue of $12.57M | 2 | Seeking Alpha | ||
| 14.12.23 | Novo Integrated Sciences, Inc. - 10-K, Annual Report | 2 | SEC Filings | ||
| 14.12.23 | Novo Integrated Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.12.23 | Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results | 257 | Business Wire | BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the "Company" or "Novo"), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary... ► Artikel lesen | |
| 04.12.23 | Novo Integrated Sciences, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.11.23 | Novo Integrated Sciences, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 3 | SEC Filings |
Seite:
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CHINA HEALTH GROUP LTD | - | - | CHINA HEALTH (00673): SUPPLEMENTAL ANNOUNCEMENT UPDATE ON LITIGATION | ||
| ONWARD MEDICAL | 4,630 | +2,89 % | ONWARD Medical NV: ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions | EINDHOVEN, the Netherlands, May 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| FRESENIUS | 27,950 | -0,07 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius anlässlich des Verkaufs von 67 Prozent der Vamed-Reha-Kliniken auf "Buy" mit einem Kursziel von 40 Euro belassen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
| RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| GERRESHEIMER | 102,00 | +0,39 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | EQS-News: Gerresheimer AG
/ Schlagwort(e): Vertrag/Beteiligung/Unternehmensbeteiligung
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen
29.04.2024... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
| ADAPTHEALTH | 10,260 | -0,87 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
Das Unternehmen NOVO INTEGRATED SCIENCES INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,523 Euro und damit -12,82 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
